Evidence map›Paper›PMID 33374351›Full record

ArticleInternational journal of molecular sciences2020

A Label-Free Cellular Proteomics Approach to Decipher the Antifungal Action of DiMIQ, a Potent Indolo[2,3-

Robert Zarnowski, Anna Jaromin, Agnieszka Zagórska, Eddie G Dominguez, Katarzyna Sidoryk, Jerzy Gubernator, David R Andes

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Robert ZarnowskiDepartment of Medicine, School of Medicine & Public Health, University of Wisconsin-Madison, Madison, WI 53706, USA.ORCID 0000-0001-6343-1500
Anna JarominDepartment of Lipids and Liposomes, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland.ORCID 0000-0002-7921-8007
Agnieszka ZagórskaDepartment of Medicinal Chemistry, Jagiellonian University Medical College, 30-688 Cracow, Poland.ORCID 0000-0003-2510-7237
Eddie G DominguezDepartment of Medicine, School of Medicine & Public Health, University of Wisconsin-Madison, Madison, WI 53706, USA.
Katarzyna SidorykDepartment of Pharmacy, Cosmetic Chemicals and Biotechnology, Team of Chemistry, Łukasiewicz Research Network-Industrial Chemistry Institute, 01-793 Warsaw, Poland.ORCID 0000-0002-1581-0693
Jerzy GubernatorDepartment of Lipids and Liposomes, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland.
David R AndesDepartment of Medicine, School of Medicine & Public Health, University of Wisconsin-Madison, Madison, WI 53706, USA.
University of Wisconsin–Madison · USUniversity of Wrocław · PLJagiellonian University · PLŁukasiewicz Research Network - Industrial Chemistry Institute · PL

Funding

Vesicle-mediated drug resistance of Candida albicans biofilmR01AI073289 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI ANDES, DAVID R, MITCHELL, AARON P · 2008 to 2025
$7.9M
NIAID NIH HHS R01 AI073289NIH HHS R01 AI073289
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ProteomicsAntifungal AgentsBiofilmsCandida albicansCarbolinesNeoplasm Proteins5,11-dimethyl-5H-indolo(2,3-b)quinolineAntifungal AgentsCarbolinesNeoplasm ProteinsantifungalbiofilmsCandidaDiMIQindoloquinolinesproteomics

Identifiers

PMID33374351
PMCPMC7795236
OpenAlexW3118167731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.